Navigation Links
Texas Medical Center, the largest concentration of medical research, educational and healthcare organizations in the world, announces the first Houston Stem Cell Summit to highlight the latest stem cell research and commercialization efforts

PHILADELPHIA, Aug. 31, 2012 /PRNewswire/ -- The New York Stem Cell Summit announced today that, in conjunction with several Houston-based medical institutions, it is launching the first Houston Stem Cell Summit to be held on Friday and Saturday, October 26 and October 27, 2012.

(Logo: )

"Since the mid-1990s," said organizer Robin Young, "the group of researchers, medical schools and hospitals at the Texas Medical Center has led the world in clinical research for the therapeutic use of stem and progenitor cells for heart disease, orthopedics, dental surgery, and ophthalmic, as well as fostering new business models for commercialization of these cellular technologies."

The Houston Stem Cell Summit will bring together, for the first time; the many and varied stem cell research and commercialization activities in Texas with the leading global researchers and entrepreneurs. Participating Texas institutions include: Baylor College of Medicine, Texas Heart Institute, Texas A&M, Rice University and MD Anderson.

About the Summit

The Houston Stem Cell Summit will be held over two days, Friday and Saturday, October 26 and October 27 at The Houstonian Hotel in Houston, Texas. In addition to highlighting the latest therapeutic research regarding the use of adult stem and progenitor cell therapies, the Summit will also provide a forum for entrepreneurs to discuss their latest efforts to commercialize stem cell therapies, and to debate and discuss FDA and other legal and regulatory issues impacting stem cell research and commercialization.

In total, the organizers expect to have more than 35 speakers, 300 attendees and a dozen of the leading commercial stem cell companies presenting over the two-day Summit.

Rick Perry Keynote Speaker

The Summit's keynote speaker is Governor Rick Perry, who himself has been treated with stem cell therapies. In addition to Governor Perry, the Summit will feature a patient panel, two in-depth debates regarding FDA and Texas Medical Board policies and a review and forecast of the current state of stem cell commercialization efforts.

Other featured speakers include:

  • James T. Willerson, M.D., President and Medical Director-Texas Heart Institute
  • J. Richard Steadman, M.D., The Steadman Clinic
  • Michael T. Thorsnes, JD, Executive Board Member, Parkinson's Association of San Diego, Inc.
  • Silviu Itescu, MBBS (Hons) FRACP, FACP, FACR, CEO, Mesoblast Limited
  • C. Randal Milles, Ph.D., President and CEO, Osiris Therapeutics, Inc.
  • David G. Eller, Chairman and CEO, Celltex Therapeutics Corp.
  • Stanley Jones, M.D., Founder/Medical Director Spinecare USA and Medical Director, Celltex Therapeutics Corp.
  • David S. Smith, JD, Attorney at Law, Pepper Hamilton
  • Christopher J. Centeno, M.D., Practicing Physician and Founder Centeno Schultz Clinic
  • Mary Pat Moyer, Ph.D., founder, President, CEO & CSO, INCELL Corporation LLC
  • Andrew S. Ittleman, Esq, CAMS, Attorney at Law, Fuerst Ittleman PL
  • Robin R. Young, CFA, CEO, RRY Publications LLC, Founder New York Stem Cell Summit

Who Should Attend

The Houston Stem Cell Summit is designed for physicians; biotech researchers; pharmaceutical and biotech analysts; hospital, business development and senior biotechnology marketing executives, as well as venture capital investors and all members of the Texas Medical Center community.


Online registration opened this week at and will remain open until October 25. For attendees who go online and register before September 15, 2012, the cost is discounted by 35%. For members of the Texas Medical Center in Houston, the cost is discounted by more than 50%. 

As part of the Houston Stem Cell Summit, Robin Young, organizer of the Houston Summit and founder of the annual New York Stem Cell Summit, is releasing the popular Adult Stem Cell Fact Book to all interested physicians, researchers, patients, and entrepreneurs. The Adult Stem Cell Fact Book is available at no charge on the Houston Stem Cell Summit web site.

About Adult Stem Cells

Approximately 1 million patients have been treated with their own stem cells since the mid-1980s in the United States.

Harvesting stem cells from adult patients and then re-injecting them into the same patient (autologous stem cell use) has been a routine therapy in U.S. medicine for decades. More recently, as stem cell research has developed, the precise method of harvesting, processing and then re-injecting into patients has changed and improved.

At the Houston Stem Cell Summit, attendees will learn the purpose of autologous and allogeneic stem cell and progenitor therapies in medicine. They'll learn of the history of autologous stem cell therapies in the United States, the number of companies that are supplying equipment to facilitate autologous stem cell therapies throughout the United States, the latest in clinical research and the size of the commercial market. Attendees will come away with a clear and comprehensive view of the future of these therapies and the use of adult stem cells in the United States.

About the Houston Stem Cell Summit Organizers

RRY Publications LLC, the organizer for the Houston Stem Cell Summit, founded the New York Stem Cell Summit in 2006. The Summit has become the premier gathering of researchers, companies and venture firms interested in the rapidly growing stem cell industry. Robin Young, the host of the Houston and New York Stem Cell Summits, is a world renowned medical technology analyst who has authored several books on regenerative medicine as well as thousands of research reports. He is quoted in such national media outlets as CBS News, the New York Times, The Wall Street Journal, Time Magazine and CNBC. 

For more information please visit

CONTACT: Suzanne Kirchner, +1-501-251-1797,


SOURCE Stem Cell Summit
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. NSBRI Renews Space Life Sciences Graduate Programs at MIT, Texas A&M
2. Worlds smallest semiconductor laser created by University of Texas scientists
3. United States Rocket Academy Welcomes XCOR Aerospace to Texas
4. Mining cleanup benefits from Texas A&M expertise
5. CEM President and CEO Delivers Commencement Address at the 2012 University of Texas at Austin Chemistry and Biochemistry Department Graduation
6. CuraLase Expands with New Franchise in Texas
7. Life Technologies Plant in Austin, Texas Named One of IndustryWeeks Top Ten Best Plants for 2011
8. Manipulating way bacteria talk could have practical applications, Texas A&M profs say
9. Global Medical Laboratories Industry
10. MarketsandMarkets: Global Refurbished Medical Equipments Market worth $8.45 Billion by 2017
11. Medical Marijuana Inc. Product, CanChew Bio-Technologies
Post Your Comments:
(Date:10/8/2015)... Fla. , Oct. 8, 2015   Intrexon ... synthetic biology, today announced the appointment of Joseph ... Environment Sector, succeeding Nir Nimrodi who continues ... Vaillancourt will direct Intrexon,s endeavors to generate sustainable, biologically ... America , where he held a variety of ...
(Date:10/8/2015)... IRVINE, Calif. , Oct. 8, 2015 ... announced its expansion into the North American market with ... Asia and Europe ... a pioneer of Target Enrichment methodology and sample preparation ... or NGS, facilitates both hereditary and somatic genetic testing ...
(Date:10/8/2015)... -- The ALS Association, in partnership with Prize4Life, is pleased ... communication technology solutions for people living with ALS. ... lateral sclerosis) is a progressive neurodegenerative disease that affects ... cord. Eventually, people with ALS lose the ability to ... total paralysis and death within two to five years ...
(Date:10/8/2015)... ... 08, 2015 , ... ProMIS Neurosciences, Inc. (TSX: PMN), announced ... commercialize intellectual property rights belonging to The University of British Columbia (UBC). This ... worldwide rights to intellectual property based on use of the ProMIS™ technology, modifications ...
Breaking Biology Technology:
... spotlight at the Institute of Physics Condensed Matter and Materials ... of London on 26-28 March. , The end ... has supplied several decades worth of remarkable increases in computing ... this pace for more than another decade in fact, ...
... N.J., March 28 Pharmasset, Inc.,(Nasdaq: VRUS ) ... Finance under an existing working capital loan agreement that,was ... loan,of $10 million in October 2007 and, at its ... November 30, 2008, provided certain conditions are,satisfied., "We ...
... Networking ... And Expo Event, ... ( ) has announced,that Merck & Co., Inc. will serve as ... May 19-20 at the Westin,Governors in Morristown, N.J. The two-day event ...
Cached Biology Technology:
(Date:9/29/2015)... 29, 2015  iDAvatars is excited to be named one ... to market. The official announcement was recently made at an ... in San Francisco , where iDAvatars presented ... IBM Watson. "It is both an honor and ... to bring to market the cognitive power of IBM Watson ...
(Date:9/28/2015)... Synaptics Inc. (NASDAQ: SYNA ), the ... Lenovo has selected Synaptics , Natural ID ™ ... smartphone, the Vibe P1. The new Vibe P1 ... and provide swift access to applications and mobile payments ... FS4202 sensor solution utilizes AES256-bit encryption of the fingerprint ...
(Date:9/10/2015)... LONDON , Sept. 10, 2015 ... This New Study Reveals Selling Opportunities and Revenue ... What,s the future of biologics, especially new drug ... You will stay ahead with exclusive market data ... can explore trends, developments, results, opportunities and sales ...
Breaking Biology News(10 mins):
... change their tune in response to urban noise? It depends ... from the Universidad Nacional Autnoma de Mxico and colleagues. Their ... in noisy conditions by means of frequency changes, others like ... in song lengths. The work is published online in Springer,s ...
... you are among the 50 percent of Americans who suffer ... warm milk to melatonin pills or prescription medications to induce ... But what if sleep could be achieved not by a ... Wake Forest Baptist Medical Center have conducted a pilot clinical ...
... Future Science Brief presents a roadmap for marine biodiversity ... ocean provides 95% of the habitable space on Earth ... the health of the oceans and their productive ecosystems ... marine life is under significant threat from climate change ...
Cached Biology News:
Goat polyclonal to XAGE1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: CGFGFRRQGEDNT, corresponding to C terminal amino acids 149-160 of Human XAGE1 Entrez Gene ID: 9...
Synaptotagmin, phosphoSer309...
... anti-phospho-PTEN (Ser385) ... amino acid region encompassing the ... (Ser385), Accession ... Quality Assurance: Routinely ...
Allophycocyanin (APC) anti-human CD193 (CCR3, CKR3) 25 tests...
Biology Products: